Health & Biotech
Creso Pharma (ASX:CPH) is a global medicinal cannabis innovator that develops cannabis and hemp-derived therapeutic, nutraceutical and lifestyle products for both people and animals.
Founded by a team of highly experienced pharmaceutical executives, Creso set out to leverage cutting edge science and research to develop, register and commercialise innovative cannabis and hemp derived products.
It was the first company to import medical cannabis to Australia and it has a presence across Canada, under its subsidiary Mernova, Switzerland and the EU, Israel, Latin America and Australia.
From the outset, Creso’s goal has been to become the world’s most trusted supplier of cannabis and hemp derived products. The company’s experienced pharmaceutical leadership team have an unparalleled track record of success commercialising a wide range of pharmaceutical and therapeutic solutions.
Creso can deliver products with standardised dosing and formulations through the application of pharmaceutical rigour, Good Manufacturing Practices (GMP) standards when appropriate and proprietary, innovative delivery technologies.
As a global company, Creso is not limited by any single market. This enables Creso to offer a diverse portfolio of solutions to the widest possible population.
By partnering with leading global companies in critical areas of research and product development, manufacturing and distribution, Creso has been able to accelerate the development and distribution of approved products allowing for broad access by patients and consumers.
KEY PEOPLE
RELATED STOCKHEAD STORIES
News
Weekly ASX small cap wrap: Have we seen the end of this happy couple?
Health & Biotech
Here’s how pot execs think the UN’s big cannabis shift can affect pot stocks in Australia
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
10 at 10: These ASX stocks have put on a strong performance this morning
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Who’s bouncing back with a bang today?
Health & Biotech
Creso Pharma picking up steam with more orders for hemp oil pet products
News
Closing Bell: Today’s biggest small cap movers on the ASX
Health & Biotech
Creso Pharma seeks to capitalise on European court ruling on CBD – ‘not narcotic’
Health & Biotech
Down-scheduling of CBD would unlock a huge opportunity for Creso Pharma
Health & Biotech
Weed Week: ‘Lame duck’ US Congress set to vote on key cannabis bill
Health & Biotech
Creso Pharma has now taken $630,000 in orders from South Africa for cannabis lozenges
Health & Biotech
Creso Pharma gains momentum with another big cannabis order in Nova Scotia
Health & Biotech
Canopy Growth Founder joins Creso Pharma
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech